U.S. judge rules for SEC in fight with House panel over insider trading probe

Published 11/16/2015, 11:29 AM
© Reuters. To match Special Report SEC/INVESTIGATIONS
HUM
-

By Nate Raymond

NEW YORK (Reuters) - A U.S. House of Representatives panel and a former staffer must comply with subpoenas issued by the U.S. Securities and Exchange Commission as part of an insider trading probe, a federal judge has ruled.

U.S. District Paul Gardephe in Manhattan, in a decision made public on Monday, said the House Ways and Means Committee must produce some documents to the SEC, and Brian Sutter, a former staff director for its healthcare subcommittee, must be deposed.

The decision came 16 months after the SEC first went to court over the committee's refusal to provide information as part of a probe of whether Sutter leaked material non-public information about Medicare reimbursement rates to a lobbyist.

The ruling came in one of the first publicly disclosed probes by federal authorities invoking provisions of a 2012 law called the STOCK ACT, which seeks to prevent people from using "political intelligence" to trade non-public information.

Both the SEC and federal prosecutors in Manhattan have launched investigations related to the alleged leak, according to court and congressional records.

The House committee had resisted complying with the SEC's demands for information, arguing in part that the U.S. Constitution shielded the panel and Sutter from being compelled to testify or produce documents.

Gardephe ruled that while the House was protected from producing some legislative documents, some documents could be produced, including administrative or personal communications between Sutter and the lobbyist's firm, Greenberg Traurig LLP.

Gardephe said the House must also produce Sutter's telephone records, with some redactions, and that the former staffer himself can be deposed.

An SEC spokeswoman declined to comment. Representatives for the House and Sutter did not immediately respond to requests for comment.

According to court filings, the SEC has been looking into an email a lobbyist at Greenberg Traurig sent to broker-dealer Height Securities regarding a deal struck in Congress about Medicare rates in 2013.

The SEC said the email was sent before the Centers for Medicare and Medicaid Services announced the rates after U.S. markets closed, and about 30 minutes before Height issued a report suggesting the change could help companies such as Humana Inc (N:HUM) and Health Net Inc.

Sutter, on the day of the announcement, had been emailing the Greenberg Traurig lobbyist about the termination of a client from the Medicare program, and they had spoken on the phone, the SEC said.

© Reuters. To match Special Report SEC/INVESTIGATIONS

The case is SEC v. Committee on Ways and Means of the U.S. House of Representatives et al, U.S. District Court, Southern District of New York, No. 14-mc-00193.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.